The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

June 30, 2026

Conditions
STEMI
Interventions
DRUG

Sacubitril-Valsartan

After initiation of the treatment of sacubitril/valsartan, the dose of the medicine will be titrated to a target level based on the systolic blood pressure of the patients. (24/26 mg, 49/51 mg and 97/103 mg, twice daily)

DRUG

Enalapril

After initiation of the treatment of enalapril, the dose of the medicine will be titrated to a target level based on the systolic blood pressure of the patients. (2.5 mg, 5 mg, and 10 mg,twice daily)

DRUG

Valsartan

For patients who were previously treated with ACEI and receiving the last dose of that agent during the last 36 hours prior to randomization, Valsartan (VAL489) 40 mg and 80 mg tablets, two doses for 1 day was used.

Trial Locations (1)

621000

West China Hospital, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER